Aerie Pharmaceuticals
Earnings Date & Report
Last updated:
Aerie Pharmaceuticals’s last earnings date was on 3 Nov 2022. It reported its quarterly earnings per share (EPS) reaching -$0.27, beating the estimated value of -$0.42 by $0.15. The company’s quarterly earnings increased by 23.25% to 36.13M US dollars compared to the same quarter of the previous year. Over the last year, Aerie Pharmaceuticals’s earnings per share have grown by 62.5%.
Aerie Pharmaceuticals stock Earnings report, Estimates & History
| 2018-02-28 | -1.21 | -1.38 |
|---|---|---|
| 2018-05-08 | -0.87 | -0.83 |
| 2018-08-08 | -0.98 | -1.14 |
| 2018-11-06 | -1.38 | -1.73 |
| 2019-02-25 | -0.87 | -0.92 |
| 2019-05-07 | -0.93 | -0.78 |
| 2019-08-07 | -0.86 | -0.8 |
| 2019-11-06 | -0.8 | -0.86 |
| 2020-02-20 | -0.77 | -0.96 |
| 2020-05-06 | -0.77 | -0.83 |
| 2020-08-06 | -0.8 | -0.83 |
| 2020-11-05 | -0.8 | -0.65 |
| 2021-02-25 | -0.73 | -0.79 |
| 2021-05-05 | -0.68 | -0.72 |
| 2021-08-04 | -0.65 | -0.67 |
| 2021-11-04 | -0.62 | -0.72 |
| 2022-02-24 | -0.67 | 1.09 |
| 2022-05-05 | -0.65 | -0.66 |
| 2022-08-04 | -0.56 | -0.32 |
| 2022-11-03 | -0.42 | -0.27 |
Estimated - a value of Apple’s earnings per share estimated by analysts based on its past and current financial statements.
Reported - a real value of Apple’s earnings per share reported by the company.
Aerie Pharmaceuticals stock earnings history by quarter
| Date | Estimated EPS | Reported EPS | Estimated revenue | Actual revenue | Earnings call | |
|---|---|---|---|---|---|---|
| 3 Nov 2022 | Beat | -$0.42 | -$0.27 | 35.48M | 36.12M | |
| 4 Aug 2022 | Beat | -$0.56 | -$0.32 | N/A | 33.31M | |
| 5 May 2022 | Missed | -$0.65 | -$0.66 | 29.37M | 29.83M | |
| 24 Feb 2022 | Beat | -$0.67 | $1.09 | 29.76M | 114.66M | Earnings Call Transcript |
| 4 Nov 2021 | Missed | -$0.62 | -$0.72 | 29.34M | 29.31M | |
| 4 Aug 2021 | Missed | -$0.65 | -$0.67 | 27.18M | 27.18M | Earnings Call Transcript |
| 5 May 2021 | Missed | -$0.68 | -$0.72 | 21.61M | 22.97M | Earnings Call Transcript |
| 25 Feb 2021 | Missed | -$0.73 | -$0.79 | 22.65M | 24.68M | Earnings Call Transcript |
| 5 Nov 2020 | Beat | -$0.8 | -$0.65 | 23.84M | 20.08M | |
| 6 Aug 2020 | Missed | -$0.8 | -$0.83 | 17.38M | 18.03M | |
| 6 May 2020 | Missed | -$0.77 | -$0.83 | 18.87M | 20.34M | |
| 20 Feb 2020 | Missed | -$0.77 | -$0.96 | 19.77M | 24.65M | Earnings Call Transcript |
| 6 Nov 2019 | Missed | -$0.8 | -$0.86 | 17.25M | 18.54M | Earnings Call Transcript |
| 7 Aug 2019 | Beat | -$0.86 | -$0.8 | 17.02M | 15.83M | Earnings Call Transcript |
| 7 May 2019 | Beat | -$0.93 | -$0.78 | 12.93M | 10.85M | Earnings Call Transcript |
| 25 Feb 2019 | Missed | -$0.87 | -$0.92 | 13.67M | 14.45M | Earnings Call Transcript |
| 6 Nov 2018 | Missed | -$1.38 | -$1.73 | 5.82M | 7.30M | Earnings Call Transcript |
| 8 Aug 2018 | Missed | -$0.98 | -$1.14 | 2.08M | 2.42M | Earnings Call Transcript |
| 8 May 2018 | Beat | -$0.87 | -$0.83 | N/A | N/A | Earnings Call Transcript |
| 28 Feb 2018 | Missed | -$1.21 | -$1.38 | N/A | N/A | Earnings Call Transcript |
Aerie Pharmaceuticals Earnings report FAQs
When is Aerie Pharmaceuticals's next Earnings date?
The company has not set the next earnings date yet. The latest Aerie Pharmaceuticals's earnings date was on 4 Nov 2021.
What are earnings?
Earnings are the net income of a company after all taxes and expenses have been deducted. They are the main figure for determining the price of a company's shares.
What does EPS stand for?
EPS stands for earnings per share, which is the basic measure of a company's earnings. It indicates how much money each share earned for the company.
How to calculate earnings per share?
Earnings per share (EPS) can be calculated by dividing a company's net income by the number of common shares outstanding. If the company pays preferred dividends, they are first subtracted from the company’s net income.
Formula:
What is earnings per share estimate?
Earnings estimate is analysts’ prediction of a company’s earnings value in the next quarter or fiscal year based on past and current financial statements of a company. It is an important indicator for both current and future investors.